Novel anti-angiogenic PEDF-derived small peptides mitigate choroidal neovascularization.

MLA

Sheibani, Nader, et al. “Novel Anti-Angiogenic PEDF-Derived Small Peptides Mitigate Choroidal Neovascularization.” Experimental Eye Research, vol. 188, Nov. 2019, p. 107798. EBSCOhost, https://doi.org/10.1016/j.exer.2019.107798.

APA

Sheibani, N., Wang, S., Darjatmoko, S. R., Fisk, D. L., Shahi, P. K., Pattnaik, B. R., Sorenson, C. M., Bhowmick, R., Volpert, O. V., Albert, D. M., Melgar-Asensio, I., & Henkin, J. (2019). Novel anti-angiogenic PEDF-derived small peptides mitigate choroidal neovascularization. Experimental Eye Research, 188, 107798. https://doi.org/10.1016/j.exer.2019.107798

Chicago

Sheibani, Nader, Shoujian Wang, Soesiawati R Darjatmoko, Debra L Fisk, Pawan K Shahi, Bikash R Pattnaik, Christine M Sorenson, et al. 2019. “Novel Anti-Angiogenic PEDF-Derived Small Peptides Mitigate Choroidal Neovascularization.” Experimental Eye Research 188 (November): 107798. doi:10.1016/j.exer.2019.107798.